The company benefited from Nutrition & Health. Sales of $853 million were reported, up 6 percent on 3 percent higher volume and 3 percent higher prices in Q4. Volume growth reflects strong demand for probiotics, cultures and enablers. Higher local prices in all regions were partly offset by unfavorable currency.
